Back to Search
Start Over
NLRC5 potentiates anti-tumor CD8+T cells responses by activating interferon-β in endometrial cancer
- Source :
- Translational Oncology; October 2023, Vol. 36 Issue: 1
- Publication Year :
- 2023
-
Abstract
- •NLRC5 potentiates antitumor responses of CD8+T cells against EC.•IFN-β promotes immunosurveillance of EC by activating CD8+T cells.•NLRC5 potentiates antitumor responses of CD8+T cells to EC by activating IFN-β.
Details
- Language :
- English
- ISSN :
- 19447124 and 19365233
- Volume :
- 36
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- Translational Oncology
- Publication Type :
- Periodical
- Accession number :
- ejs63646804
- Full Text :
- https://doi.org/10.1016/j.tranon.2023.101742